Liquidia Corp (LQDA)
10.15
+0.03
(+0.30%)
USD |
NASDAQ |
Nov 21, 16:00
10.16
+0.01
(+0.10%)
After-Hours: 20:00
Liquidia Revenue (Quarterly): 4.448M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.448M |
| June 30, 2024 | 3.659M |
| March 31, 2024 | 2.972M |
| December 31, 2023 | 4.531M |
| September 30, 2023 | 3.678M |
| June 30, 2023 | 4.786M |
| March 31, 2023 | 4.493M |
| December 31, 2022 | 5.36M |
| September 30, 2022 | 3.165M |
| June 30, 2022 | 3.918M |
| March 31, 2022 | 3.492M |
| December 31, 2021 | 3.215M |
| September 30, 2021 | 3.179M |
| June 30, 2021 | 3.376M |
| March 31, 2021 | 3.084M |
| December 31, 2020 | 0.7396M |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 8.072M |
| March 31, 2019 | |
| December 31, 2018 | 0.5684M |
| September 30, 2018 | 0.1697M |
| June 30, 2018 | 1.043M |
| March 31, 2018 | 0.926M |
| December 31, 2017 | 1.816M |
| September 30, 2017 | 1.821M |
| June 30, 2017 | 1.982M |
| March 31, 2017 | 1.639M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.7396M
Minimum
Dec 2020
5.36M
Maximum
Dec 2022
3.631M
Average
3.576M
Median
Revenue (Quarterly) Benchmarks
| United Therapeutics Corp | 748.90M |
| Arcturus Therapeutics Holdings Inc | 38.82M |
| Paragon 28 Inc | 62.34M |
| Tonix Pharmaceuticals Holding Corp | 2.822M |
| AIM ImmunoTech Inc | 0.035M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.16M |
| Total Expenses (Quarterly) | 33.64M |
| EPS Diluted (Quarterly) | -0.30 |
| Enterprise Value | 654.69M |
| Gross Profit Margin (Quarterly) | 64.82% |
| Profit Margin (Quarterly) | -520.6% |
| Earnings Yield | -16.06% |
| Normalized Earnings Yield | -15.47 |